Skip to main content
. 2019 Sep 30;24(3):149–157. doi: 10.6065/apem.2019.24.3.149

Table 3.

Laboratory and radiographic testing in the evaluation of amenorrhea

Findings Associations
Laboratory testing (refer to local reference values)
 17-hydroxyprogesterone level (collected at 8:00 AM) High: nonclassic CAH
 Anti-Müllerian hormone High: Functional hypothalamic amenorrhea, PCOS
Low: Primary ovarian insufficiency
 Complete blood count and metabolic panel Abnormal: chronic disease (e.g., elevated liver enzymes in functional hypothalamic amenorrhea)
 Estradiol Low: Poor endogenous estrogen production (suggestive of poor current ovarian function)
 Follicle stimulating hormone and luteinizing hormone High: primary ovarian insufficiency; Turner syndrome, FSH receptor mutation
Low: functional hypothalamic amenorrhea
Normal: PCOS; intrauterine adhesions; multiple others
 Free and total T, DHEA-S High: hyperandrogenism, PCOS, ovarian or adrenal tumor, CAH, Cushing syndrome
 T/DHT ratio (normal <30:1) High: 5-α-reductase deficiency
 At puberty, serum LH, and T High: androgen insensitivity syndrome
 Karyotype Abnormal: turner syndrome, rare chromosomal disorders
 Prolactin High: pituitary adenoma, medications, hypothyroidism, other neoplasm
 Thyroid-stimulating hormone High: hypothyroidism
Low: hyperthyroidism
Radiographic testing
 Dual-energy X-ray absorptiometry Evaluation of fracture risk
 MRI of the adrenal glands Androgen-secreting adrenal tumor
 MRI of the brain (including sella) Tumor (e.g., microadenoma)
 Pelvic organ ultrasonography or MRI Morphology of pelvic organs, polycystic ovarian morphology, androgen-secreting ovarian tumor

CAH, congenital adrenal hyperplasia; PCOS, polycystic ovary syndrome; FSH, follicle stimulating hormone; DHEA-S, dehydroepiandrosterone sulfate; DHT, dihysrotestosterone; LH, luteinizing hormone; MRI, magnetic resonance imaging; T, testosterone.

Modified from Klein et al., Am Fam Physician 2019;100:39-48, with permission of American Academy of Family Physicians. [5]